(1)
Sato, T.; Maekawa, M. .; Mano, N.; Abe, T.; Yamaguchi, H. Role of OATP4C1 in Renal Handling of Remdesivir and Its Nucleoside Analog GS-441524: The First Approved Drug for Patients With COVID-19. J Pharm Pharm Sci 2021, 24, 227-236.